Microalgae-derived EPA oil is a next-generation sustainable Omega-3 ingredient produced from Nannochloropsis microalgae, a natural primary producer of eicosapentaenoic acid (EPA). Unlike traditional marine oils derived from fish or krill, microalgae EPA is produced directly from photosynthetic microalgae cultivation, providing a pure, marine-independent, and environmentally responsible source of Omega-3 fatty acids.

This microalgae oil is naturally rich in polar lipids, including phospholipids, glycolipids, and betaine lipids, which contribute to superior biological absorption compared with conventional triglyceride-type fish oils. The unique lipid composition supports efficient delivery of EPA in the human body and may play a role in lipid metabolism, cardiovascular health, and anti-inflammatory pathways.

Microalgae EPA oil contains EPA without DHA, making it particularly suitable for formulations focusing specifically on cardiovascular health and triglyceride management. In addition, the absence of marine food-chain contaminants provides an additional safety advantage for high-purity nutritional applications.

The ingredient is widely used in dietary supplements, functional foods, nutraceutical formulations, and pharmaceutical intermediate research. With increasing global demand for sustainable Omega-3 sources, microalgae EPA oil has emerged as a leading alternative to fish-derived oils.

This product is suitable for softgels, capsules, functional beverages, nutrition powders, and other health-oriented formulations. OEM and customized specifications are available to meet specific formulation requirements for global manufacturers.